Viatris Inc (VTRS)

12.38 -0.16 (-1.24%) USD  |  NASDAQ  |  Dec 23, 11:50
More

Viatris Max Drawdown (5Y): 82.57% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for VTRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Lexicon Pharmaceuticals Inc 94.56%
Moderna Inc 92.39%
Baxter International Inc 64.18%
Gilead Sciences Inc 41.71%
Perspective Therapeutics Inc 91.70%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -19.38
Beta (5Y) 0.9644
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 35.84%
Historical Sharpe Ratio (5Y) -0.1814
Historical Sortino (5Y) -0.2537
Monthly Value at Risk (VaR) 5% (5Y Lookback) 17.26%